AdaptHealth Corp. (AHCO)
Healthcare
- Fundamental
- 3
- Sentiment
- 2
- Technical
- 2
Do Nothing: no run-date source in a partial run (runDate absent; inherited currentDate 2026-09-11 untrusted); cannot anchor chart or event windows. Additionally, qualitativeScore is 2 (below the required floor of 3); strategy requires qualitativeScore ≥ 3 before any bullish entry.
Company overview
AdaptHealth Corp. provides home medical equipment and services across the U.S., focusing on sleep therapy, diabetes treatment, and chronic care. The company supplies CPAP devices, glucose monitors, and in-home oxygen services, catering to Medicare, Medicaid, and commercial insurance beneficiaries.
Fundamental
fairValuation and cash generation are attractive, but high leverage and goodwill impairments weigh on profitability.
Mixed fundamentals: valuation and operating cash generation look attractive, but leverage is high and recent GAAP losses are driven by recurring goodwill impairments. SEC filings show refinancing with covenant compliance and no going-concern warning, yet liquidity is relatively tight and reimbursement/legal risks remain. FundamentalScore: 3 (watch leverage/FCF trend closely).
Sentiment
weakRecent data breach and earnings miss have negatively impacted sentiment, with no offsetting bullish catalysts.
Dominant near-term driver is the freshly disclosed 4.1M-patient data breach (announced, 2026-09-10) layered on top of an early-August Q2 miss, guidance cut and ~26% selloff; the media delta is determinate and flat, negative on both windows (baseline ≈ −0.23 → scoring ≈ −0.17), with no bullish catalyst offsetting it. Moderate red-flag cap applied (weak sentiment with no offsetting bullish catalyst).
Technical
weakThe stock is experiencing an unconfirmed oversold bounce, lacking a trend reversal.
Bounce-only price action: price 6.045 sits above the fast SMA20 (5.82) and EMA9 (5.96) after reclaiming them off the 5.21 August low, but remains far below the EMA21 (6.23), SMA50 (7.95), and a declining SMA200 (9.92) with MACD line still negative (−0.45) and only the histogram turning positive (+0.18); ADX14 20.6 shows no directional trend strength and RSI14 43.5 is mid-range. Mixed-to-weak chart quality is a 2, and the fail-closed run-date branch caps the emitted score at 2 regardless (no trustworthy run-date source in this partial run).
You’re looking at 2026-09-11 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.